Background: Hematopoietic Stem Cell Transplant (HCT) is a potentially curative treatment for hematologic malignancies, including multiple myeloma. Biomarker investigation can guide identification of HCT recipients at-risk for poor outcomes. MicroRNAs (miRNAs) are a class of non-coding RNAs involved in the modulation and regulation of pathological processes and are emerging as prognostic and predictive biomarkers for multiple health conditions. This pilot study aimed to examine miRNA profiles associated with HCT-related risk factors and outcomes in patients undergoing autologous HCT. Methods: Patients eligible for autologous HCT were recruited and blood samples and HCT-related variables were collected. Differential expression analysis of miRNA was conducted on 24 patient samples to compare changes in miRNA profile in HCT eligible patients before and after transplant. Results: Unsupervised clustering of differentially expressed (p < .05) miRNAs pre- and post- HCT identified clusters of up- and down-regulated miRNAs. Four miRNAs (miR-125a-5p, miR-99b-5p, miR-382–5p, miR-145–5p) involved in hematopoiesis (differentiation of progenitor cells, granulocyte function, thrombopoiesis, and tumor suppression) were significantly downregulated post-HCT. Correlation analyses identified select miRNAs associated with risk factors (such as frailty, fatigue, cognitive decline) and quality of life pre- and post-HCT. Select miRNAs were correlated with platelet engraftment. Conclusion: Future studies should examine miRNA signatures in larger cohorts in association with HCT outcomes; and expand investigations in patients receiving allogeneic transplants. This will lead to identification of biomarkers for risk stratification of HCT recipients.
AgueliC.CammarataG.SalemiD.DagninoL.NicolettiR.La RosaM.MessanaF.MarfiaA.BicaM. G.ConiglioM. L.PaganoM.FabbianoF.SantoroA. (2010). 14q32/miRNA clusters loss of heterozygosity in acute lymphoblastic leukemia is associated with up-regulation of BCL11a. American Journal of Hematology, 85(8), 575–578. https://doi.org/10.1002/ajh.21758
AmodioN.Di MartinoM. T.NeriA.TagliaferriP.TassoneP. (2013). Non-coding RNA: A novel opportunity for the personalized treatment of multiple myeloma. Expert Opinion on Biological Therapy, 13(Issue SUPPL.1), S125–S137. https://doi.org/10.1517/14712598.2013.796356
4.
AndersenC. L.JensenJ. L.ØrntoftT. F. (2004). Normalization of real-time quantitative reverse transcription-PCR data: A model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Research, 64(15), 5245–5250. https://doi.org/10.1158/0008-5472.CAN-04-0496
5.
AroraM.ChenY.WuJ.HagemanL.NessE.KungM.FranciscoL.BosworthA.WeisdorfD. J.FormanS. J.LandierW.PamukçuoğluM.ArmenianS. H.WongF. L.BhatiaS. (2021). Longitudinal trajectory of frailty in blood or marrow transplant survivors: Report from the blood or Marrow transplant survivor study. Cancer, 127(5), 794–800. https://doi.org/10.1002/cncr.33313
6.
BhatlekarS.JacobS.ManneB. K.GuoL.DenormeF.TugolukovaE. A.CodyM. J.KosakaY.RigoutsosI.CampbellR. A.RowleyJ. W.O’ConnellR. M.BrayP. F. (2021). Megakaryocyte-specific knockout of the Mir-99b/let7e/125a cluster lowers platelet count without altering platelet function. Blood Cells, Molecules & Diseases, 92, 102624. https://doi.org/10.1016/j.bcmd.2021.102624
BolonY.AtshanR.Allbee-JohnsonM.Estrada-MerlyN.LeeS. (2022). Current use and outcome of hematopoietic stem cell transplantation: CIBMTR summary slides. https://www.cibmtr.org.
9.
ChengZ.ZhouL.HuK.DaiY.PangY.ZhaoH.WuS.QinT.HanY.HuN.ChenL.WangC.ZhangY.WuD.KeX.ShiJ.FuL. (2018). Prognostic significance of microRNA-99a in acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplantation, 53(9), 1089–1095. https://doi.org/10.1038/s41409-018-0146-0
DatoS.CroccoP.IannoneF.PassarinoG.RoseG. (2022). Biomarkers of frailty: miRNAs as common signatures of impairment in cognitive and physical domains. Biology, 11(8). https://doi.org/10.3390/biology11081151
12.
GuillaumeT.RubinsteinD. B.SymannM. (1998). Immune reconstitution and immunotherapy after autologous hematopoietic stem cell transplantation. Blood, 92(5), 1471–1490. https://www.ncbi.nlm.nih.gov/pubmed/9716573
13.
GullettJ. M.ChenZ.O’SheaA.AkbarM.BianJ.RaniA.PorgesE. C.FosterT. C.WoodsA. J.ModaveF.CohenR. A. (2020). MicroRNA predicts cognitive performance in healthy older adults. Neurobiology of Aging, 95, 186–194. https://doi.org/10.1016/j.neurobiolaging.2020.07.023
14.
HausserJ.ZavolanM. (2014). Identification and consequences of miRNA-target interactions--beyond repression of gene expression. Nature Reviews Genetics, 15(9), 599–612. https://doi.org/10.1038/nrg3765
15.
HeL.HannonG. J. (2004). MicroRNAs: Small RNAs with a big role in gene regulation. Nature Reviews Genetics, 5(7), 522–531. https://doi.org/10.1038/nrg1379
16.
KaoC.-Y.JiangJ.ThompsonW.PapoutsakisE. T. (2022). miR-486-5p and miR-22-3p enable megakaryocytic differentiation of hematopoietic stem and progenitor cells without Thrombopoietin. International Journal of Molecular Sciences, 23(10). https://doi.org/10.3390/ijms23105355
17.
KongY. W.Ferland-McColloughD.JacksonT. J.BushellM. (2012). MicroRNAs in cancer management. The Lancet Oncology, 13(Issue 6), E249–E258. https://doi.org/10.1016/S1470-2045(12)70073-6
KtenaY. P.DionysiouM.GondekL. P.CookeK. R. (2023). The impact of epigenetic modifications on allogeneic hematopoietic stem cell transplantation. Frontiers in Immunology, 14. https://doi.org/10.3389/fimmu.2023.1188853
20.
LamJ.Van Den BoschM.WegrzynJ.ParkerJ.IbrahimR.SlowskiK.ChangL.Martinez-HøyerS.CondorelliG.BoldinM.DengY.UmlandtP.FullerM.KarsanA. (2018). MiR-143/145 differentially regulate hematopoietic stem and progenitor activity through suppression of canonical TGFβ signaling. Nature Communications, 9(1). https://doi.org/10.1038/s41467-018-04831-3
21.
LangloisF.VuT. T. M.KergoatM. J.ChasséK.DupuisG.BhererL. (2012). The multiple dimensions of frailty: Physical capacity, cognition, and quality of life.International Psychogeriatrics. https://doi.org/10.1017/S1041610212000634
Leukemia and Lymphoma Society. (2022). Facts and statistics overview.
24.
LiangH.SunH.YangJ.YiC. (2018). miR-145-5p reduces proliferation and migration of hepatocellular carcinoma by targeting KLF5. Molecular Medicine Reports, 17(6), 8332–8338. https://doi.org/10.3892/mmr.2018.8880
25.
LiguoriM.NuzzielloN.SimoneM.AmorosoN.ViterboR. G.TangaroS.ConsiglioA.GiordanoP.BellottiR.TrojanoM. (2019). Association between miRNAs expression and cognitive performances of pediatric multiple sclerosis patients: A pilot study. Brain and Behavior, 9(2), Article e01199. https://doi.org/10.1002/brb3.1199
26.
LiuD.ZhongL.YuanZ.YaoJ.ZhongP.LiuJ.YaoS.ZhaoY.LiuL.ChenM.LiL.LiuB. (2019). miR-382-5p modulates the ATRA-induced differentiation of acute promyelocytic leukemia by targeting tumor suppressor PTEN. Cellular Signalling, 54, 1–9. https://doi.org/10.1016/j.cellsig.2018.11.012
27.
LoveM. I.HuberW.AndersS. (2014). Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biology, 15(12). https://doi.org/10.1186/s13059-014-0550-8
28.
Massanett AparicioJ.XuY.LiY.ColantuoniC.DastgheybR.WilliamsD. W.AsahchopE. L.McMillianJ. M.PowerC.FujiwaraE.GillM. J.RubinL. H. (2021). Plasma microRNAs are associated with domain-specific cognitive function in people with HIV. AIDS, 35(11), 1795–1804. https://doi.org/10.1097/QAD.0000000000002966
29.
MohanrajL.WolfH.SilveyS.LiuJ.ToorA.Swift-ScanlanT. (2022). DNA methylation changes in autologous hematopoietic stem cell transplant patients. Biological Research For Nursing, p. 10998004221135628. https://doi.org/10.1177/10998004221135628
30.
MouhieddineT. H.SperlingA. S.ReddR.ParkJ.LeventhalM.GibsonC. J.ManierS.NassarA. H.CapellettiM.HuynhD.BustorosM.Sklavenitis-PistofidisR.TahriS.HornburgK.DumkeH.ItaniM. M.BoehnerC. J.LiuC.-J.AlDubayanS. H.GhobrialI. M. (2020). Clonal hematopoiesis is associated with adverse outcomes in multiple myeloma patients undergoing transplant. Nature Communications, 11(1), 2996.
31.
O’ConnellR. M.ChaudhuriA. A.RaoD. S.GibsonW. S. J.BalazsA. B.BaltimoreD. (2010). MicroRNAs enriched in hematopoietic stem cells differentially regulate long-term hematopoietic output. Proceedings of the National Academy of Sciences of the United States of America, 107(32), 14235–14240. https://doi.org/10.1073/pnas.1009798107
32.
PamukcuogluM.BhatiaS.WeisdorfD. J.DeForT. E.UstunC.NayarM.HoltanS. G.JurdiN. E.ThyagarajanB.BrunsteinC. G.BachanovaV.WarlickE. D.SeverseikeB.TeH. S.LundT.AroraM. (2019). Hematopoietic cell transplant–related toxicities and mortality in frail recipients. Biology of Blood and Marrow Transplantation. https://doi.org/10.1016/j.bbmt.2019.07.030
33.
PichiorriF.SuhS. S.RocciA.De LucaL.TaccioliC.SanthanamR.ZhouW.BensonD. M.HofmainsterC.AlderH.GarofaloM.Di LevaG.VoliniaS.LinH. J.PerrottiD.KuehlM.AqeilanR. I.PalumboA.CroceC. M. (2010). Downregulation of p53-inducible microRNAs 192, 194, and 215 impairs the p53/MDM2 autoregulatory loop in multiple myeloma development. Cancer Cell, 18(4), 367–381. https://doi.org/10.1016/j.ccr.2010.09.005
34.
PiscopoP.LacorteE.FeligioniM.MayerF.CrestiniA.PiccoloL.BacigalupoI.FilaretiM.FiculleE.ConfaloniA.VanacoreN.CorboM. (2019). MicroRNAs and mild cognitive impairment: A systematic review. Ageing Research Reviews, 50, 131–141. https://doi.org/10.1016/j.arr.2018.11.005
35.
PorrataL. F.InwardsD. J.AnsellS. M.MicallefI. N.JohnstonP. B.GastineauD. A.LitzowM. R.WintersJ. L.MarkovicS. N. (2008). Early lymphocyte recovery predicts superior survival after autologous stem cell transplantation in non-Hodgkin lymphoma: A prospective study. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation, 14(7), 807–816. https://doi.org/10.1016/j.bbmt.2008.04.013
36.
PulikkanJ. A.PeramangalamP. S.DenglerV.HoP. A.PreudhommeC.MeshinchiS.ChristopeitM.NibourelO.Müller-TidowC.BohlanderS. K.TenenD. G.BehreG. (2010). C/EBPα regulated microRNA-34a targets E2F3 during granulopoiesis and is down-regulated in AML with CEBPA mutations. Blood, 116(25), 5638–5649. https://doi.org/10.1182/blood-2010-04-281600
37.
RajkumarS. V. (2022). Multiple myeloma: 2022 update on diagnosis, risk stratification, and management. American Journal of Hematology, 97(8), 1086–1107. https://doi.org/10.1002/ajh.26590
38.
RevelleW. (2023). psych: Procedures for psychological, psychometric, and personality research. Northwestern University. https://cran.r-project.org/package=psych
39.
SevcikovaA.FridrichovaI.NikolaievaN.KalinkovaL.OmelkaR.MartiniakovaM.CiernikovaS. (2023). Clinical significance of microRNAs in hematologic malignancies and hematopoietic stem cell transplantation. Cancers, 15(9). https://doi.org/10.3390/cancers15092658
40.
SongM.-S.RossiJ. J. (2017). Molecular mechanisms of dicer: Endonuclease and enzymatic activity. Biochemical Journal, 474(10), 1603–1618. https://doi.org/10.1042/BCJ20160759
WilliamsA. M.ZentC. S.JanelsinsM. C. (2016). What is known and unknown about chemotherapy-related cognitive impairment in patients with haematological malignancies and areas of needed research. British Journal of Haematology. https://doi.org/10.1111/bjh.14211
44.
WojtowiczE. E.WalasekM. A.BroekhuisM. J. C.WeersingE.RitsemaM.AusemaA.BystrykhL. V.de HaanG. (2014). MicroRNA-125 family members exert a similar role in the regulation of murine hematopoiesis. Experimental Hematology, 42(10), 909–918.e1. https://doi.org/10.1016/j.exphem.2014.06.010
45.
WongK. Y.LiangR.SoC. C.JinD. Y.CostelloJ. F.ChimC. S. (2011). Epigenetic silencing of MIR203 in multiple myeloma. British Journal of Haematology, 154(5), 569–578. https://doi.org/10.1111/j.1365-2141.2011.08782.x
46.
ZagoE.Dal MolinA.DimitriG. M.XumerleL.PirazziniC.BacaliniM. G.MaturoM. G.AzevedoT.SpasovS.Gómez-GarreP.PeriñánM. T.JesúsS.BaldelliL.SambatiL.Calandra-BuonauraG.GaragnaniP.ProviniF.CortelliP.MirP.PROPAG-AGEING Consortium. (2022). Early downregulation of hsa-miR-144-3p in serum from drug-naïve Parkinson’s disease patients. Scientific Reports, 12(1), 1330. https://doi.org/10.1038/s41598-022-05227-6
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
